SVB Leerink Upgrades Regeneron Pharma (REGN) to Outperform
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $800.47 +0.44%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Join SI Premium – FREE
SVB Leerink analyst Andrew Berens upgraded Regeneron Pharma (NASDAQ: REGN) from Market Perform to Outperform with a price target of $976.00 (from $834.00).
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $820.00 yesterday.
You May Also Be Interested In
- Oppenheimer Upgrades Intuitive Surgical (ISRG) to Outperform, 'Crowding Out Competitors Strategically Smart'
- Siloam International Hospitals Tbk PT (SILO:IJ) PT Lowered to IDR3,000 at Macquarie
- Nomura/Instinet Downgrades Pearl Abyss Corp. (263750:KS) (BRFS) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
